New Treatment Strategies for Dengue and Other Flaviviral Diseases (eBook)
276 Seiten
Wiley (Verlag)
978-0-470-05801-5 (ISBN)
This book features contributions from the world's leading researchers working on dengue and related flaviviruses who examine the current state of the art in the molecular biology of the dengue virus. Particular emphasis is placed on the structure and function of the virus and the targeting of virus proteins by potential antiviral agents. The pathogenesis of dengue and dengue haemorrhagic fever are discussed in detail, especially the target cells and the specific receptors on these cells, thereby developing a clear overview of host and viral factors that contribute to dengue haemorrhagic fever. Finally, the book reviews the therapeutic options, paying particular attention to ways in which vector, host and environment can play a critical role in the spread of this disease.
With dengue fever and other emerging viral diseases becoming increasingly prevalent around the world, this book provides valuable insight into the virus that causes this disease and potential ways to manage it. It is essential reading for all those working in tropical diseases, public health and virology.
Praise from the reviews:
'The book provides an excellent summary of dengue/flavivirus research and is important for individuals and institutions interested in emerging infectious diseases.' MICROBIOLOGY TODAY
The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.
Dengue virus is a member of the Flaviviridae family, which includes viruses associated with human diseases such as yellow fever, Japanese encephalitis and hepatitis C. Dengue fever is transmitted by mosquitoes, principally Aedes aegypti. There are four serotypes of dengue virus, of which DENV-2 has been the most prevalent in many recent epidemics. Following primary infection, lifelong immunity develops, preventing repeated assault by the same serotype. However, the non-neutralizing antibodies from a previous infection or maternally acquired antibodies are thought to form complexes with a different serotype during a subsequent infection and cause dengue haemorrhagic fever/dengue shock syndrome, which can be fatal. There is no treatment or vaccine available today that can combat this emerging and uncontrolled disease. This book features contributions from the world s leading researchers working on dengue and related flaviviruses who examine the current state of the art in the molecular biology of the dengue virus. Particular emphasis is placed on the structure and function of the virus and the targeting of virus proteins by potential antiviral agents. The pathogenesis of dengue and dengue haemorrhagic fever are discussed in detail, especially the target cells and the specific receptors on these cells, thereby developing a clear overview of host and viral factors that contribute to dengue haemorrhagic fever. Finally, the book reviews the therapeutic options, paying particular attention to ways in which vector, host and environment can play a critical role in the spread of this disease. With dengue fever and other emerging viral diseases becoming increasingly prevalent around the world, this book provides valuable insight into the virus that causes this disease and potential ways to manage it. It is essential reading for all those working in tropical diseases, public health and virology. Praise from the reviews: "e;The book provides an excellent summary of dengue/flavivirus research and is important for individuals and institutions interested in emerging infectious diseases."e; MICROBIOLOGY TODAY
The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.
Chair's introduction (Charles Rice).
Dengue/dengue hemorrhagic fever: history and current status
(Duane J. Gubler).
Discussion.
Molecular biology of flaviviruses (Eva Harris, Katherine L.
Holden, Dianna Edgil, Charlotta Polacek and Karen Clyde).
Discussion.
Development of novel antivirals against flaviviruses (Chinmay G.
Patkar and Richard J. Kuhn).
Discussion.
Entry functions and antigenic structure of flavivirus envelope
proteins Karin Stiasny, Stefan Kiermayr and Franz X. Heinz).
Discussion.
General discussion I.
Multiple enzyme activities of flavivirus proteins (R.
Padmanabhan, N. Mueller, E. Reichert, C. Yon, T. Teramoto, Y. Kono,
R. Takhampunya, S. Ubol, N. Pattabiraman, B. Falgout, V. K. Ganesh
and K. Murthy).
Discussion.
Towards the design of flavivirus helicase/NTPase inhibitors:
crystallographic and mutagenesis studies of the dengue virus NS3
helicase catalytic domain (Ting Xu, Aruna Sampath, Alex Chao,
Daying Wen, Max Nanao, Dahai Luo, Patrick Chene, Subhash G.
Vasudevan and Julien Lescar).
Discussion.
Finding new medicines for flaviviral targets (Thomas H. Keller,
Yen Liang Chen, John E. Knox, Siew Pheng Lim, Ngai Ling Ma, Sejal
J. Patel, Aruna Sampath, Qing Yin Wang, Zheng Yin and Subhash G.
Vasudevan).
Discussion.
Structural and functional analysis of dengue virus RNA (Diego
Alvarez, Maria F. Lodeiro, Claudia Filomatori, Silvana Fucito, Juan
Mondotte and Andrea Gamarnik).
Discussion.
Organization of flaviviral replicase proteins in virus induced
membranes: a role for NS1' in Japanese encephalitis virus RNA
synthesis (Vijaya Satchidanandam, Pradeep Devappa Uchil and Priti
Kumar).
Discussion.
CRM1 dependent nuclear export of dengue virus type-2 NS5
(Melinda J. Pryor, Stephen M. Rawlinson, Peter J. Wright and David
A. Jans).
Discussion.
T cell responses and dengue haemorrhagic fever (Gavin Screaton
and Juthathip Mongkolsapaya).
Discussion.
The evolutionary biology of dengue virus (Edward C. Holmes).
Discussion.
Developing vaccines against flavivirus diseases: past success,
present hopes and future challenges (John R. Stephenson).
Discussion.
A genomics approach to understanding host response during dengue
infection (Martin L. Hibberd, Ling Ling, Thomas Tolfvenstam, Wayne
Mitchell, Chris Wong, Vladimir A. Kuznetsov, Joshy George, Swee-Hoe
Ong, Yijun Ruan, Chia L Wei, Feng Gu, Joshua Fink, Andy Yip, Wei
Liu, Mark Schreiber and Subhash G. Vasudevan).
Discussion.
Mouse and hamsters models rodent models for the study of therapy
against flavivirus infections (Nathalie Charlier, Pieter Leyssen,
Erik De Clercq and Johan Neyts).
Discussion.
Secretion of flaviviral non-structural protein NS1: from
diagnosis to pathogenesis (S. Alcon-LePoder, P. Sivard, M.-T.
Drouet, A. Talarmin, C. Rice and M. Flamand).
Discussion.
Final discussion.
Index of contributors.
Subject index.
"...this reviewer was highly moved by the painstaking
investigations and careful evaluation of results by the
participants of this symposium." (Journal of Tropical
Pediatrics, February 2008)
"This is an excellent update of many aspects of dengue and the
difficult quest for treatment and prevention. It is a valuable
resource for new researchers coming to this fascinating field."
(Doody's Health Services)
"...painstaking investigations and careful
evaluation..." (Journal of Tropical Pediatrics, January
2007)
"...provides an excellent summary of dengue/flavivirus research
and is important for individual and institutions interested in
emerging infectious diseases." (Microbiology Today,
November 2007)
"...this reviewer was highly moved by the painstaking
investigations and careful evaluation of results by the
participants of this symposium." (Journal of Tropical
Pediatrics, February 2008)
| Erscheint lt. Verlag | 2.10.2006 |
|---|---|
| Reihe/Serie | Novartis Foundation Symposium |
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete |
| Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
| Naturwissenschaften ► Biologie ► Mikrobiologie / Immunologie | |
| Technik | |
| Schlagworte | Biotechnologie i. d. Biowissenschaften • Biotechnology • Biowissenschaften • clinical microbiology • Immunologie • immunology • Klinische Mikrobiologie • Life Sciences • Medical Science • Medizin • Microbiology & Virology • Mikrobiologie u. Virologie |
| ISBN-10 | 0-470-05801-3 / 0470058013 |
| ISBN-13 | 978-0-470-05801-5 / 9780470058015 |
| Haben Sie eine Frage zum Produkt? |
PDF (Adobe DRM)Größe: 15,2 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
